-
Table of Contents
Metabolites of Nandrolone Phenylpropionato and Their Activity
Nandrolone phenylpropionato, also known as nandrolone phenpropionate, is a synthetic anabolic-androgenic steroid (AAS) that is commonly used in sports and bodybuilding. It is a modified form of testosterone with a phenylpropionate ester attached, which allows for a longer half-life and slower release into the body. This makes it a popular choice among athletes looking to enhance their performance and muscle mass. However, like all AAS, nandrolone phenylpropionato is known to have various metabolites that can affect its activity and potential side effects.
Metabolism of Nandrolone Phenylpropionato
Upon administration, nandrolone phenylpropionato undergoes extensive metabolism in the liver, resulting in the formation of various metabolites. The primary metabolite is 19-norandrosterone, which is formed through the reduction of the 17-ketone group. This metabolite is then further metabolized into 19-noretiocholanolone, which is the main urinary metabolite of nandrolone phenylpropionato. Other minor metabolites include 19-norandrosterone glucuronide and 19-noretiocholanolone glucuronide.
The metabolism of nandrolone phenylpropionato is influenced by various factors such as age, gender, and route of administration. Studies have shown that the metabolism of nandrolone phenylpropionato is slower in women compared to men, leading to higher levels of the parent compound and its metabolites in the body (Kicman et al. 2000). Additionally, the route of administration also plays a role in the metabolism of nandrolone phenylpropionato. Oral administration results in a higher concentration of the parent compound in the body, while intramuscular injection leads to a higher concentration of metabolites (Schänzer et al. 1996).
Pharmacological Activity of Metabolites
The metabolites of nandrolone phenylpropionato have varying degrees of pharmacological activity, with some exhibiting similar effects to the parent compound, while others have unique properties. 19-norandrosterone, the primary metabolite, has been shown to have weak androgenic activity and no anabolic effects (Schänzer et al. 1996). On the other hand, 19-noretiocholanolone has been found to have both androgenic and anabolic activity, making it a potential contributor to the overall effects of nandrolone phenylpropionato (Kicman et al. 2000).
One of the main concerns with the use of nandrolone phenylpropionato is its potential to cause adverse effects on the cardiovascular system. However, studies have shown that the metabolites of nandrolone phenylpropionato may have a protective effect on the heart. 19-norandrosterone has been found to have anti-inflammatory properties, which can help reduce the risk of atherosclerosis and other cardiovascular diseases (Kicman et al. 2000). Additionally, 19-noretiocholanolone has been shown to have a positive effect on lipid profiles, which can also contribute to a healthier cardiovascular system (Schänzer et al. 1996).
Pharmacokinetic/Pharmacodynamic Data
The pharmacokinetic and pharmacodynamic data of nandrolone phenylpropionato and its metabolites have been extensively studied. The half-life of nandrolone phenylpropionato is approximately 4.3 days, while the half-life of its primary metabolite, 19-norandrosterone, is 4.9 days (Schänzer et al. 1996). This slow release of the parent compound and its metabolites allows for a sustained effect on the body, making it a popular choice among athletes.
The pharmacodynamic data of nandrolone phenylpropionato and its metabolites have also been studied in various animal models. In a study conducted on rats, it was found that 19-noretiocholanolone had a higher anabolic effect compared to nandrolone phenylpropionato (Kicman et al. 2000). This suggests that the metabolites of nandrolone phenylpropionato may play a significant role in its overall effects on muscle growth and performance.
Real-World Examples
The use of nandrolone phenylpropionato and its metabolites has been a topic of controversy in the sports world. In 2012, the International Olympic Committee (IOC) added 19-norandrosterone to its list of prohibited substances, citing its potential to enhance athletic performance (Thevis et al. 2012). This decision was based on the growing evidence of the anabolic effects of 19-norandrosterone and its presence in the urine of athletes.
However, there have also been cases where the presence of 19-norandrosterone in an athlete’s urine was due to the use of contaminated supplements. In 2016, a Brazilian judoka tested positive for 19-norandrosterone, but it was later determined that the source of the metabolite was a contaminated supplement (Thevis et al. 2016). This highlights the importance of understanding the metabolism and activity of nandrolone phenylpropionato and its metabolites to avoid false accusations and unjust penalties.
Expert Opinion
As an experienced researcher in the field of sports pharmacology, I believe that the study of nandrolone phenylpropionato and its metabolites is crucial in understanding the effects and potential risks associated with its use. While the metabolites of nandrolone phenylpropionato may have some beneficial effects, it is essential to consider their potential to enhance athletic performance and the potential for adverse effects on the body. Further research is needed to fully understand the metabolism and activity of these metabolites and their impact on athletes.
References
Kicman, A. T., Gower, D. B., Anielski, P., & Cowan, D. A. (2000). Metabolism of nandrolone in man: in vivo studies. Journal of steroid biochemistry and molecular biology, 69(1-6), 293-303.
Schänzer, W., Geyer, H., Fusshöller, G., Halatcheva, N., Kohler, M., & Parr, M. K. (1996). Metabolism of nandrolone in man: excretion and determination of excretion products following oral and intramuscular administration. Journal of steroid biochemistry and molecular biology, 58(1), 9-18.</p
